Last reviewed · How we verify

NCT07392359

Zhicheng TAVR Robot

Not yet recruiting NA Last updated 6 February 2026
What this trial tests

NA trial testing TAVR Assistance System in Aortic Stenosis Treated With TAVI in 158 participants. Not yet recruiting.

Timeline
15 February 2026
Primary endpoint
15 October 2026
15 October 2026

Quick facts

Lead sponsorZhicheng Medical Technology (Jiaxing) Co, Ltd
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment158
Start date15 February 2026
Primary completion15 October 2026
Estimated completion15 October 2026

Drugs / interventions tested

Conditions studied

Sponsor

Zhicheng Medical Technology (Jiaxing) Co, Ltd

Who can join

Adults 65 to 100, any sex, with Aortic Stenosis Treated With TAVI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Use of the Transcatheter Aortic Valve Replacement Surgical Assist System and its Disposable Kit in Patients With Severe Aortic Stenosis to Evaluate the Safety and Efficacy of the Transcatheter Aortic Valve Replacement Surgical Assist System and its Disposable Kit for Use as an Adjunct to Transcatheter Aortic Valve Replacement

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07392359.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing